A lesion on the heart is any area of abnormal tissue within or on the heart’s structures, whether caused by disease, injury, infection, or a developmental defect present from birth. The term is deliberately broad: cardiologists use “lesion” to describe everything from a patch of scar left behind after a heart attack to a calcified valve, a tumor, a hole between heart chambers, or a cluster of inflamed cells. Because the word covers so many different problems, hearing that you have a “heart lesion” tells you very little on its own. What matters is the type, location, and underlying cause.
Why Doctors Use Such a Vague Word
In everyday conversation, “lesion” sounds alarming and specific. In medicine it is almost the opposite: a placeholder that means “something abnormal here.” A radiologist reading a CT scan might note a lesion before anyone knows whether it is a benign growth, scar tissue, or something more serious. The word stays in the report until further testing narrows the diagnosis. So if a doctor mentions a cardiac lesion during a scan review, the next question is always “what kind?” rather than “how bad?” The answer to that second question depends entirely on the first.
Coronary and Ischemic Lesions
The most common heart lesions in adults are tied to coronary artery disease. Fatty deposits called plaques build up inside the arteries that feed the heart muscle. These plaques are themselves lesions of the artery wall, and they come in different forms. Two of the most clinically important are plaque rupture and plaque erosion, which are the two main culprit lesion types behind acute coronary syndrome, the umbrella term for heart attacks and unstable angina.1PubMed. Peripheral atherosclerosis in acute coronary syndrome patients with plaque rupture vs plaque erosion When a plaque ruptures or erodes, a blood clot forms and blocks blood flow, starving part of the heart muscle of oxygen.
If the blockage lasts long enough to kill heart muscle cells, scar tissue gradually replaces the dead area over the following weeks.2PubMed Central. Physiological Implications of Myocardial Scar Structure That scar is a permanent structural lesion. It does not contract the way healthy muscle does, so it can weaken the heart’s pumping ability and sometimes serve as a source of abnormal electrical signals that trigger arrhythmias. Studies using cardiac MRI in the general population have found that some people carry these scars without ever realizing they had a heart attack, a phenomenon sometimes called unrecognized myocardial scar.3PubMed Central. Unrecognized myocardial scar by late-gadolinium-enhancement cardiovascular magnetic resonance
Inflammatory and Autoimmune Lesions
Not all heart lesions start with blocked arteries. Inflammation can damage the heart muscle directly. Myocarditis, an inflammation of the heart muscle itself, can be triggered by viral infections, autoimmune reactions, or sometimes medications. The resulting lesions are patches of inflamed, swollen, and sometimes dying tissue scattered through the myocardium. In one diagnostic case report, post-mortem biopsy revealed active non-granulomatous myocarditis without the characteristic granulomas that would point to sarcoidosis, illustrating how similar these inflammatory lesions can look on imaging yet differ at the tissue level.4PubMed Central. Diagnostic dilemma between probable cardiac sarcoidosis and non-granulomatous myocarditis
Cardiac sarcoidosis is a particularly tricky example. In this condition, clusters of immune cells called granulomas form inside the heart muscle, disrupting its normal electrical activity and sometimes weakening it. When the granulomas are limited to the heart and do not appear in the lungs or lymph nodes, it is called isolated cardiac sarcoidosis, and it is considered the hardest form to diagnose and the most dangerous.5PubMed Central. Diagnostic challenges in isolated cardiac sarcoidosis Patients can present with heart block, dangerous arrhythmias, or sudden cardiac death with little warning.
Congenital Heart Lesions
Some heart lesions are present from birth. Congenital heart defects are structural abnormalities that form while the heart is developing in the womb. The most common single defect is a ventricular septal defect (VSD), a hole in the wall between the heart’s two lower chambers. VSDs account for up to about 30% of all congenital heart abnormalities and are among the most frequently encountered lesions in clinical practice.6Congenital Heart Defects – Recent Advances. Ventricular Septal Defects: A Review Many small VSDs close on their own during childhood. Larger ones may require surgical repair to prevent the heart from overworking.
A broader group of congenital lesions involves obstructions on the left side of the heart, including conditions like hypoplastic left heart syndrome, bicuspid aortic valve, and coarctation of the aorta. These defects sometimes cluster in families, with higher-than-average sibling recurrence risk, yet the known genetic causes explain only about 10 to 20 percent of cases.7PubMed Central. Genetic Etiology of Left-Sided Obstructive Heart Lesions In other words, something is clearly heritable, but researchers are still working out the full genetic picture. Adults living with congenital heart disease face a higher risk of stroke and systemic embolism than the general population, and that risk starts earlier in life and rises with age.8International Journal of Cardiology Congenital Heart Disease. Stroke and systemic embolism in adult congenital heart disease
Valvular Lesions and Calcification
Heart valves can develop lesions of their own. The most studied is calcific aortic stenosis, where the aortic valve gradually thickens and stiffens over years as calcium deposits build up in its leaflets. The process involves chronic inflammation, genetic susceptibility, lipoprotein deposition, and cells within the valve that shift toward bone-like behavior and actively lay down calcium.9PubMed Central. Calcific aortic stenosis Eventually the valve opening narrows enough to obstruct blood flow out of the heart, causing symptoms like breathlessness, chest pain on exertion, and fainting. Valve replacement is currently the only definitive treatment once the obstruction becomes severe.
Infective endocarditis creates a different kind of valvular lesion. Bacteria colonize the valve surface and form vegetations, which are lumpy masses of bacteria, blood clots, and inflammatory debris. These vegetations can destroy valve tissue, cause the valve to leak, and break off in fragments that travel to the brain or other organs, causing strokes or abscesses. People with pre-existing valve abnormalities or prosthetic valves are at higher risk.
Cardiac Tumors
Tumors of the heart are uncommon but do occur. They may be discovered because of symptoms or found incidentally during imaging ordered for an unrelated reason.10PubMed Central. Cardiac myxoma: a comprehensive review Among benign primary heart tumors, cardiac myxoma is the second most common type after papillary fibroelastoma. Myxomas usually grow in the left atrium, attached to the wall by a stalk, and can cause symptoms by blocking blood flow through the valve or by shedding fragments that embolize to the brain or limbs. Surgical removal is usually curative, and recurrence is rare unless the patient has a genetic syndrome predisposing them to multiple myxomas.
Malignant primary heart tumors are far rarer but more dangerous. More commonly, cancers that start elsewhere in the body spread to the heart secondarily. Metastatic heart lesions from lung, breast, or blood cancers are actually more frequent than tumors originating in the heart itself.
Radiation and Toxic Causes
Certain medical treatments can create heart lesions as an unintended side effect. Radiation therapy directed at the chest, commonly used for breast cancer, lymphoma, and some lung cancers, causes fibrosis throughout the heart’s structures over time. This substantially raises the risk of coronary artery disease, valve damage, arrhythmias, pericardial disease, and cardiomyopathy.11PubMed Central. Radiation-Induced Cardiovascular Disease: Review of an Underrecognized Pathology The damage can appear years or even decades after treatment, which is why cancer survivors who received chest radiation are monitored with periodic cardiac screening long after their cancer is cured.
Some chemotherapy drugs, particularly anthracyclines like doxorubicin, are directly toxic to heart muscle cells and can cause a dilated cardiomyopathy. The lesion in this case is diffuse weakening and thinning of the heart muscle rather than a discrete spot. Alcohol abuse, certain recreational drugs, and heavy metal exposure can produce similar patterns of toxic heart damage.
Symptoms That Point to a Heart Lesion
The symptoms of a heart lesion depend far more on what the lesion does to heart function than on what it is made of. A scar from a heart attack and a granuloma from sarcoidosis can produce identical symptoms if they disrupt the same electrical pathway or weaken the same section of muscle. That said, certain patterns are common:
- Chest pain: Especially with exertion, may indicate a coronary plaque restricting blood flow or a valve obstruction limiting output.
- Breathlessness: A lesion that weakens pumping ability or obstructs flow causes fluid to back up into the lungs.
- Palpitations or fainting: Scar tissue, inflammation, or congenital pathways can trigger abnormal heart rhythms, from harmless extra beats to life-threatening ventricular arrhythmias.
- Fatigue and exercise intolerance: A heart working against a narrowed valve or pumping with a large area of dead muscle cannot deliver enough blood during activity.
- Stroke symptoms: Lesions that create clots or shed tissue fragments can cause sudden neurological problems when those fragments travel to the brain.
Some heart lesions produce no symptoms at all. A small VSD that closes in childhood, a tiny scar from a silent heart attack, or a benign tumor discovered on a CT scan ordered for something else may never cause trouble. The growing use of chest CT imaging has increased the rate of incidental cardiac findings, many of which turn out to be clinically insignificant but still require follow-up evaluation to be sure.12PubMed Central. Benign incidental cardiac findings in chest and cardiac CT imaging
How Heart Lesions Are Diagnosed
No single test identifies every type of heart lesion. Diagnosis typically starts with the least invasive tools and escalates based on what is found.
Echocardiography
An echocardiogram, essentially an ultrasound of the heart, is usually the first imaging test ordered. It shows valve motion, chamber size, wall thickness, and pumping strength in real time. Standard transthoracic echocardiography (performed from outside the chest) works well for many lesions, but transesophageal echocardiography, where a probe is passed into the esophagus to get closer to the heart, is superior for localizing and characterizing cardiac masses and blood clots, particularly in the left atrium.13Mayo Clinic Proceedings. Transesophageal Echocardiography If a mass is seen on a standard echo, the transesophageal approach often follows to get a clearer picture.
Cardiac MRI
Cardiac magnetic resonance imaging has become the go-to tool for characterizing the tissue that makes up a lesion. Its standout technique is late gadolinium enhancement (LGE), where a contrast agent highlights areas of damaged or abnormal tissue. LGE is considered the most relevant cardiac MRI tool for distinguishing scar from healthy muscle, and its pattern helps differentiate ischemic damage (which follows the distribution of a blocked artery) from non-ischemic damage (which may appear in the mid-wall or on the outer surface of the heart).14PubMed Central. Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies Among different cardiomyopathies, specific patterns of LGE can help point toward the correct diagnosis without a biopsy.
CT and Nuclear Imaging
Coronary CT angiography provides detailed images of the coronary arteries and can identify plaques, calcium deposits, and stenosis. For suspected infections or inflammatory conditions, FDG-PET scanning, which uses a radioactive sugar tracer to highlight metabolically active tissue, has proven useful for assessing cardiovascular infection and inflammatory processes.15PubMed Central. Assessing cardiovascular infection and inflammation with FDG-PET The active granulomas of cardiac sarcoidosis, for example, light up on PET scans because they are metabolically hungry, giving doctors a way to track disease activity without repeated biopsies.
Endomyocardial Biopsy
When imaging alone cannot deliver a definitive answer, a small sample of heart tissue can be taken through a catheter threaded into the heart. This endomyocardial biopsy remains the gold standard for confirming certain diagnoses, particularly infiltrative diseases like amyloidosis and inflammatory conditions like myocarditis. The trade-off is that biopsy is invasive and its diagnostic yield is relatively low: one large study of over 700 heart failure patients found that biopsy delivered a definitive diagnosis in roughly one in five cases, with amyloidosis being the most common finding.16PubMed Central. Derivation and validation of a machine learning-driven score to predict the diagnostic yield of endomyocardial biopsy Researchers are developing machine-learning tools to better predict which patients will benefit from biopsy before putting them through the procedure.
When a Lesion Becomes an Emergency
Some heart lesions carry a risk of embolism, meaning a piece of the lesion or a clot that forms on it breaks free and travels through the bloodstream. When that fragment lodges in an artery supplying the brain, the result is a stroke. One case report documented a patient with a blood clot in transit across the chambers of the heart: brain MRI showed multiple acute infarcts consistent with an embolic source, and review of the chest CT confirmed a filling defect stretching from the right atrium across the interatrial septum into the left atrium.17Inquisiva Open. Embolic Stroke Associated with an Intracardiac Thrombus In-Transit in Saddle Pulmonary Embolism
Anticoagulant therapy can sometimes resolve intracardiac blood clots, though outcomes vary. In a study of 82 patients with acute cardioembolic stroke, intracardiac thrombus was identified by echocardiography in 15, and most of those started on anticoagulant therapy showed clot regression over time.18PubMed. Regression of intracardiac thrombus after embolic stroke However, in at least one case the clot embolized to the arm shortly after anticoagulation was started, a reminder that treatment itself carries risk. The decision to anticoagulate depends on the size and location of the thrombus, the patient’s bleeding risk, and whether the underlying cause (such as atrial fibrillation or a structural defect) can be addressed.
People with congenital heart disease face particularly elevated embolic risk. Complex defects, cyanotic heart disease, and surgical modifications like the Fontan circulation all predispose to clot formation, and additional factors like atrial arrhythmias and heart failure compound the danger.8International Journal of Cardiology Congenital Heart Disease. Stroke and systemic embolism in adult congenital heart disease
Artificial Intelligence in Lesion Detection
One area where cardiac lesion diagnosis is changing fast is the integration of AI into imaging interpretation. Coronary angiography, the catheter-based procedure where dye is injected into the coronary arteries and X-ray images are captured, has traditionally depended on a cardiologist’s eye to judge the severity of narrowings. A recently developed deep-learning system for real-time detection and measurement of coronary stenosis achieved recall and precision scores above 0.89 in internal testing and above 0.76 externally, with segmentation accuracy exceeding 0.92 in both settings.19PubMed Central. Artificial Intelligence Powered Real-Time Coronary Stenosis Recognition and Quantification in Angiography These tools are not replacing cardiologists, but they may serve as a second pair of eyes, flagging lesions that a busy operator might underestimate or miss during a fast-moving procedure. Similar AI approaches are being explored for echocardiography, cardiac MRI, and CT, where the volume of imaging data is growing faster than the specialist workforce available to read it.